CHMP recommends EU approval of Roche’s Gazyvaro™ for people with chronic lymphocytic leukemia
23 May 2014 | By Roche
Roche announced that the EU Committee for Medicinal Products for Human Use recommended that the European Commission approve Gazyvaro in combination with chlorambucil for the treatment of adult patients with previously untreated chronic lymphocytic leukemia...